Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egerton

Showing results (591-600 of 623) with videos related to

Pageof 63
Sort By:
BMJ Open|November 21, 2022
Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort studyEdward Millgate, Kira Griffiths, Alice Egerton, et al.
BMJ Open|June 16, 2025
Implementing best practice for peripheral intravenous cannula use in Australian emergency departments: a stepped-wedge cluster-controlled trial and health economic analysis protocolDiana Egerton-Warburton, Lisa Kuhn, Joanne Enticott, et al.
Schizophrenia Bulletin|January 7, 2017
Elevated Striatal Dopamine Function in Immigrants and Their Children: A Risk Mechanism for PsychosisAlice Egerton, Oliver D Howes, Sylvain Houle, et al.
Emergency Medicine Australasia : EMA|March 16, 2019
Driving change: A partnership study protocol using shared emergency department data to reduce alcohol-related harmPeter Miller, Nicolas Droste, Diana Egerton-Warburton, et al.
Scientific Reports|January 28, 2017
Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegenerationPing Kei Yip, Alejandro Carrillo-Jimenez, Paul King, et al.
Schizophrenia Bulletin|March 14, 2023
Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical TrialSubash Raj Susai, Melanie Föcking, David Mongan, et al.
International Journal for Parasitology|November 1, 1996
Eprinomectin: a novel avermectin for use as a topical endectocide for cattleW L Shoop, J R Egerton, C H Eary, et al.
The New Phytologist|December 9, 2024
Leaf nonstructural carbohydrate residence time, not concentration, correlates with leaf functional traits following the leaf economic spectrum in woody plantsShinichi Asao, Danielle A Way, Matthew H Turnbull, et al.
Scientific Reports|September 5, 2014
A gigantic, exceptionally complete titanosaurian sauropod dinosaur from southern Patagonia, ArgentinaKenneth J Lacovara, Matthew C Lamanna, Lucio M Ibiricu, et al.
Neuropharmacology|December 5, 2003
Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonistM J Gunthorpe, H K Rami, J C Jerman, et al.
Pageof 63

Showing results (591-600 of 623) with videos related to

Sort By:
Pageof 63
BMJ Open|November 21, 2022
Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort studyEdward Millgate, Kira Griffiths, Alice Egerton, et al.
BMJ Open|June 16, 2025
Implementing best practice for peripheral intravenous cannula use in Australian emergency departments: a stepped-wedge cluster-controlled trial and health economic analysis protocolDiana Egerton-Warburton, Lisa Kuhn, Joanne Enticott, et al.
Schizophrenia Bulletin|January 7, 2017
Elevated Striatal Dopamine Function in Immigrants and Their Children: A Risk Mechanism for PsychosisAlice Egerton, Oliver D Howes, Sylvain Houle, et al.
Emergency Medicine Australasia : EMA|March 16, 2019
Driving change: A partnership study protocol using shared emergency department data to reduce alcohol-related harmPeter Miller, Nicolas Droste, Diana Egerton-Warburton, et al.
Scientific Reports|January 28, 2017
Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegenerationPing Kei Yip, Alejandro Carrillo-Jimenez, Paul King, et al.
Schizophrenia Bulletin|March 14, 2023
Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical TrialSubash Raj Susai, Melanie Föcking, David Mongan, et al.
International Journal for Parasitology|November 1, 1996
Eprinomectin: a novel avermectin for use as a topical endectocide for cattleW L Shoop, J R Egerton, C H Eary, et al.
The New Phytologist|December 9, 2024
Leaf nonstructural carbohydrate residence time, not concentration, correlates with leaf functional traits following the leaf economic spectrum in woody plantsShinichi Asao, Danielle A Way, Matthew H Turnbull, et al.
Scientific Reports|September 5, 2014
A gigantic, exceptionally complete titanosaurian sauropod dinosaur from southern Patagonia, ArgentinaKenneth J Lacovara, Matthew C Lamanna, Lucio M Ibiricu, et al.
Neuropharmacology|December 5, 2003
Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonistM J Gunthorpe, H K Rami, J C Jerman, et al.
Pageof 63